Primary |
Narcolepsy |
32.1% |
Hypersomnia |
14.0% |
Somnolence |
11.0% |
Fatigue |
7.0% |
Sleep Apnoea Syndrome |
5.7% |
Attention Deficit/hyperactivity Disorder |
5.0% |
Depression |
3.3% |
Insomnia |
3.3% |
Multiple Sclerosis |
3.3% |
Obsessive-compulsive Disorder |
2.3% |
Contraception |
1.7% |
Epilepsy |
1.7% |
Sleep Disorder |
1.7% |
Cataplexy |
1.3% |
Circadian Rhythm Sleep Disorder |
1.3% |
Ankylosing Spondylitis |
1.0% |
Drug Dependence |
1.0% |
Hypertension |
1.0% |
Liver Disorder |
1.0% |
Schizophrenia |
1.0% |
|
Urticaria |
13.0% |
Product Substitution Issue |
9.0% |
Somnolence |
8.0% |
Suicide Attempt |
7.0% |
Rash |
6.0% |
Stress Cardiomyopathy |
6.0% |
Tachycardia |
5.0% |
Convulsion |
4.0% |
Epilepsy |
4.0% |
Irritability |
4.0% |
Nausea |
4.0% |
Pregnancy On Oral Contraceptive |
4.0% |
Theft |
4.0% |
Vomiting |
4.0% |
Completed Suicide |
3.0% |
Drug Prescribing Error |
3.0% |
Hypertension |
3.0% |
Mania |
3.0% |
Tension |
3.0% |
Tremor |
3.0% |
|
Secondary |
Drug Use For Unknown Indication |
25.8% |
Product Used For Unknown Indication |
23.9% |
Narcolepsy |
11.4% |
Fatigue |
5.2% |
Depression |
4.7% |
Somnolence |
4.2% |
Hypersomnia |
3.9% |
Cataplexy |
3.5% |
Multiple Sclerosis |
2.4% |
Attention Deficit/hyperactivity Disorder |
2.0% |
Sleep Apnoea Syndrome |
1.8% |
Circadian Rhythm Sleep Disorder |
1.5% |
Parkinson's Disease |
1.4% |
Convulsion |
1.3% |
Hypertension |
1.3% |
Insomnia |
1.3% |
Sedation |
1.3% |
Convulsion Prophylaxis |
1.2% |
Apathy |
1.0% |
Chronic Fatigue Syndrome |
1.0% |
|
Completed Suicide |
11.7% |
Nausea |
10.4% |
Death |
9.1% |
Vomiting |
8.4% |
Respiratory Arrest |
6.5% |
Toxicity To Various Agents |
6.5% |
Urticaria |
6.5% |
Cardio-respiratory Arrest |
3.9% |
Drug Toxicity |
3.9% |
Mania |
3.9% |
Weight Decreased |
3.9% |
Irritability |
3.2% |
Somnolence |
3.2% |
Suicide Attempt |
3.2% |
Dyskinesia |
2.6% |
Hyperhidrosis |
2.6% |
Intentional Drug Misuse |
2.6% |
Oral Intake Reduced |
2.6% |
Pregnancy On Oral Contraceptive |
2.6% |
Road Traffic Accident |
2.6% |
|
Concomitant |
Drug Use For Unknown Indication |
21.5% |
Product Used For Unknown Indication |
15.5% |
Multiple Sclerosis |
13.6% |
Narcolepsy |
7.3% |
Cataplexy |
6.5% |
Pain |
4.9% |
Depression |
4.5% |
Hypertension |
4.0% |
Fatigue |
3.8% |
Relapsing-remitting Multiple Sclerosis |
2.7% |
Somnolence |
2.4% |
Insomnia |
2.3% |
Rheumatoid Arthritis |
2.0% |
Anxiety |
1.9% |
Diabetes Mellitus |
1.5% |
Sleep Disorder |
1.3% |
Gastrooesophageal Reflux Disease |
1.2% |
Hypersensitivity |
1.1% |
Asthma |
1.0% |
Constipation |
1.0% |
|
Vomiting |
18.6% |
Weight Decreased |
10.2% |
Nausea |
8.8% |
Somnolence |
5.8% |
Progressive Multifocal Leukoencephalopathy |
5.1% |
Urinary Tract Infection |
5.1% |
Pneumonia |
4.7% |
Weight Increased |
4.7% |
Death |
4.4% |
Visual Impairment |
3.7% |
Multiple Sclerosis Relapse |
3.4% |
Tremor |
3.4% |
Multiple Sclerosis |
3.1% |
Syncope |
3.1% |
Urticaria |
3.1% |
White Blood Cell Count Decreased |
3.1% |
Suicidal Ideation |
2.7% |
Myocardial Infarction |
2.4% |
Pain |
2.4% |
Sleep Apnoea Syndrome |
2.4% |
|
Interacting |
Depression |
11.5% |
Ill-defined Disorder |
11.5% |
Fatigue |
6.7% |
Hypertension |
5.7% |
Multiple Sclerosis Relapse |
5.7% |
Neuralgia |
5.7% |
Sinus Disorder |
5.7% |
Sinusitis |
5.7% |
Vitamin Supplementation |
5.7% |
Epilepsy |
5.1% |
Insomnia |
4.1% |
Product Used For Unknown Indication |
3.8% |
Anxiety |
2.9% |
Arthritis |
2.9% |
Hyperlipidaemia |
2.9% |
Injection Site Pain |
2.9% |
Paraesthesia |
2.9% |
Prophylaxis Against Gastrointestinal Ulcer |
2.9% |
Relapsing-remitting Multiple Sclerosis |
2.9% |
Sexual Dysfunction |
2.9% |
|
Appendicitis |
14.6% |
Tourette's Disorder |
14.6% |
Convulsion |
9.8% |
Epilepsy |
9.8% |
Pancreatitis Chronic |
7.3% |
Serotonin Syndrome |
7.3% |
Umbilical Hernia |
7.3% |
Decreased Appetite |
4.9% |
Mania |
4.9% |
Rash Erythematous |
4.9% |
Weight Decreased |
4.9% |
Hallucination |
2.4% |
Sleep Apnoea Syndrome |
2.4% |
Unintended Pregnancy |
2.4% |
Urine Odour Abnormal |
2.4% |
|